基于多参数检测的自身抗体状态可准确估计结缔组织病分类并识别临床相关疾病聚类
研究纳入908例系统性红斑狼疮、系统性硬化症、干燥综合征、未分化结缔组织病、特发性炎症性肌病及健康对照,检测29种自身抗体,用XGBoost模型仅基于抗体滴度进行分类,平均准确率60.84±4.05%,平均AUC为88.99±2.50%;层次聚类识别出4个聚类,各聚类具有不同临床特征。
要点
- 仅基于29种自身抗体滴度的XGBoost模型分类平均准确率为60.84±4.05%,平均AUC为88.99±2.50%。
- 层次聚类识别出4个聚类,CL1以典型SLE特征为主,CL2以干燥综合征为主并含部分SLE和UCTD。
- CL3最大且异质性最高,以低滴度或低患病率自身抗体为特征;CL4仅含抗Jo1阳性患者。
核心结论
- 扩展的多参数自身抗体检测可不依赖临床特征对结缔组织病患者进行准确分类,且按自身抗体滴度聚类能识别具有相似临床特征但最终诊断不同的结缔组织病聚类。
研究设计与样本
- 研究纳入系统性红斑狼疮、系统性硬化症、干燥综合征、未分化结缔组织病、特发性炎症性肌病及健康对照共908例受试者,检测血清29种自身抗体。
- 构建仅基于自身抗体滴度的XGBoost模型并评估分类准确率,随后建立层次聚类模型并比较各聚类间临床和实验室特征。
主要发现
- 分类模型平均准确率为60.84±4.05%,平均受试者工作特征曲线下面积为88.99±2.50%,各组间存在显著差异。
- 聚类分析识别出4个聚类:CL1包含具有典型SLE特征的患者。
- CL2包含大多数干燥综合征患者,以及部分具有干燥综合征样特征的SLE和UCTD患者。
- CL4仅包含抗Jo1阳性患者。
- CL3为最大且异质性最高的聚类,包含所有剩余受试者,总体以低滴度或低患病率自身抗体为特征。
关键数值与推荐
- 分类模型平均准确率为60.84±4.05%,平均受试者工作特征曲线下面积为88.99±2.50%,各组间存在显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Assessment of circulating autoantibodies represents one of the earliest diagnostic procedures in patients with suspected connective tissue disease (CTD), providing important information for disease diagnosis, identification and prediction of potential clinical manifestations. The purpose of this study was to evaluate the ability of multiparametric assay to correctly classify patients with multiple CTDs and healthy controls (HC), independent of clinical features, and to evaluate whether serological status could identify clusters of patients with similar clinical features. METHODS: Patients with systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Sjogren's syndrome (SjS), undifferentiated connective tissue disease (UCTD), idiopathic inflammatory myopathies (IIM) and HC were enrolled. Serum was tested for 29 autoantibodies. An XGBoost model, exclusively based on autoantibody titres was built and classification accuracy was evaluated. A hierarchical clustering model was subsequently developed and clinical/laboratory features compared among clusters. RESULTS: 908 subjects were enrolled. The classification model showed a mean accuracy of 60.84±4.05% and a mean area under the receiver operator characteristic curve of 88.99±2.50%, with significant discrepancies among groups. Cluster analysis identified four clusters (CL). CL1 included patients with typical features of SLE. CL2 included most patients with SjS, along with some SLE and UCTD patients with SjS-like features. CL4 included anti-Jo1 patients only. CL3 was the largest and most heterogeneous, including all the remaining subjects, overall characterised by low titre or lower-prevalence autoantibodies. CONCLUSION: Extended multiparametric autoantibody assay allowed an accurate classification of CTD patients, independently of clinical features. Clustering according to autoantibody titres is able to identify clusters of CTD subjects with similar clinical features, independently of their final diagnosis.
引用
- Cafaro G, Bartoloni E, Baldini C, et al. Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters. RMD Open. 2023. PMID: 37734871. doi:10.1136/rmdopen-2023-003365
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。